Nobuhsia Akamatsu

Dr. Nobuhsia Akamatsu

Artificial Organ and Transplantation Surgery Division, Department of Surgery, University of Tokyo, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2018 in Transplant International
Verified
Journal Article
Closed access
PDF file
TSTsuyoshi Shimamura
Tsuyoshi Shimamura
Nobuhsia AkamatsuNobuhsia Akamatsu
Nobuhsia Akamatsu
MFMasato Fujiyoshi
Masato Fujiyoshi
AKAtushi Kawaguchi
Atushi Kawaguchi
SMSatoshi Morita
Satoshi Morita
TSThe Japanese Liver Transplantation Society
The Japanese Liver Transplantation Society
Expansion of the liver transplantation indication criteria for patients with hepatocellular carcinoma (HCC) has long been debated. Here we propose new, expanded living‐donor liver transplantation (LDLT) criteria for HCC patients based on a retrospective data analysis of the Japanese nationwide survey. A total of 965 HCC patients undergoing LDLT were included, 301 (31%) of whom were beyond the Milan criteria. Here, we applied the Greenwood formula to investigate new criteria enabling the maximal enrollment of candidates while securing a 5‐year recurrence rate (95% upper confidence limit) below 10% by examining various combinations of tumor numbers and serum alpha‐fetoprotein values, and maintaining the maximal nodule diameter at 5 cm. Finally, new expanded criteria for LDLT candidates with HCC, the 5‐5‐500 rule (nodule size ≤ 5 cm in diameter, nodule number ≤ 5, and alfa‐fetoprotein value ≤ 500 ng/ml), were established as a new regulation with a 95% confidence interval of a 5‐year recurrence rate of 7.3% (5.2‐9.3) and a 19% increase in the number of eligible patients. In addition, the 5‐5‐500 rule could identify patients at high risk of recurrence, among those within and beyond the Milan criteria. In conclusion, the new criteria – the 5‐5‐500 rule – might provide rational expansion for LDLT candidates with HCC.

31 March 2022 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
JAJunichi Arita
Junichi Arita
AIAkihiko Ichida
Akihiko Ichida
RNRihito Nagata
Rihito Nagata
YMYuichiro Mihara
Yuichiro Mihara
YKYoshikuni Kawaguchi
Yoshikuni Kawaguchi
KHKiyoshi Hasegawa
Kiyoshi Hasegawa

2 June 2016 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
KIKyoji Ito
Kyoji Ito
Nobuhsia AkamatsuNobuhsia Akamatsu
Nobuhsia Akamatsu
AIAkihiko Ichida
Akihiko Ichida
DIDaisuke Ito
Daisuke Ito
JKJunichi Kaneko
Junichi Kaneko
NKNorihiro Kokudo
Norihiro Kokudo
Simultaneous splenectomy (SPX) is preferentially performed in living donor liver transplantation (LDLT) to modulate portal flow; increase postoperative platelet count, especially among those with hepatitis C virus (HCV) infection; and modulate the immunologic status in ABO‐incompatible cases. The negative effects of the procedure, however, are not well established. Records of 395 LDLTs performed at our institution, including 169 (42.8%) patients with simultaneous SPX and 226 (57.2%) patients with spleen preservation, were reviewed with special reference to the simultaneous SPX cases. The most common indication for SPX was HCV‐related disease (n = 114), followed by low preoperative platelet count (n = 52), and other reasons (n = 3). Simultaneous splenectomy did not increase the platelet count in the early postoperative period, but the incidence of reoperation for postoperative hemorrhage was increased, mainly at the SPX site, within the first week. In addition, the operative time, intraoperative blood loss, and incidence of lethal infectious disease were significantly higher in the SPX group, whereas the incidence of small‐for‐size syndrome was comparable between groups. Finally, SPX was an independent predictor for both postoperative hemorrhage (odds ratio [OR] = 2.451; 95% confidence interval [CI] = 1.285‐4.815; P = 0.006) and lethal infectious complication (OR = 3.748; 95% CI = 1.148‐14.001; P = 0.03). In conclusion, on the basis of the present findings, we do not recommend simultaneous SPX in LDLT. Liver Transplantation 22 1526–1535 2016 AASLD.

28 February 2024 in American Journal of Transplantation
Verified
Journal Article
Open access
ZLZhihao Li
Zhihao Li
ARAshwin Rammohan
Ashwin Rammohan
VGvasanthakumar gunasekaran
vasanthakumar gunasekaran
SHSuyoung Hong
Suyoung Hong
ICItsuko Chih-Yi Chen
Itsuko Chih-Yi Chen
PCPierre-Alain Clavien
Pierre-Alain Clavien
In living-donor liver transplantation, biliary complications including bile leaks and biliary anastomotic strictures remain significant challenges, with incidences varying across different centers. This multicentric retrospective study (2016-2020) included 3633 adult patients from 18 centers and aimed to identify risk factors for these biliary complications and their impact on patient survival. Incidences of bile leaks and biliary strictures were 11.4% and 20.6%, respectively. Key risk factors for bile leaks included multiple bile duct anastomoses (Odds Ratio [OR] 1.8), Roux-en-hepaticojejunostomy (OR 1.4), and a history of major abdominal surgery (OR 1.4). For biliary anastomotic strictures, risk factors were ABO-incompatibility (OR 1.4), blood loss >1 liter (OR 1.4), and previous abdominal surgery (OR 1.7). Patients experiencing biliary complications had extended hospital stays, increased incidence of major complications, and higher Comprehensive Complication Index (CCI®) scores. The impact on graft survival became evident after accounting for immortal time bias using time-dependent covariate survival analysis. Bile leaks and biliary anastomotic strictures were associated with adjusted hazard ratios of 1.7 and 1.8 for graft survival, respectively. The study underscores the importance of minimizing these risks through careful donor selection and preoperative planning, as biliary complications significantly affect graft survival despite available effective treatments.

19 December 2015 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
KIKyoji Ito
Kyoji Ito
Nobuhsia AkamatsuNobuhsia Akamatsu
Nobuhsia Akamatsu
KTKeigo Tani
Keigo Tani
DIDaisuke Ito
Daisuke Ito
JKJunichi Kaneko
Junichi Kaneko
NKNorihiro Kokudo
Norihiro Kokudo
Special care must be taken in hepatic vein reconstruction to avoid outflow block in living donor liver transplantation (LDLT) with a right liver graft. We have used cryopreserved homologous veins to reconstruct the right hepatic vein (RHV), middle hepatic vein (MHV), MHV tributaries (V5 and V8), and inferior right hepatic vein (IRHV). The reconstruction of V5, V8, and IRHV was based on the estimated congestive volume, calculated by the computed tomography volumetry, to secure the functional graft volume of 40% of the recipient standard liver volume. Among 262 right liver LDLT recipients, the number of reconstructed RHVs, MHVs, V5s, V8s, and IRHVs was 262, 48, 110, 111, and 147, respectively, and the overall patency was 95%, 100%, 36%, 58%, and 86%, respectively. Although the patency of the RHVs and MHVs was satisfactory, that of the V5s, V8s, and IRHVs was suboptimal. Patency of the IRHVs (86%, 126/147) was significantly better than that of both V5s (36%, 40/110) and V8s (58%, 64/111; P < 0.001). In addition, the estimated volume drained by IRHVs was significantly greater than that of V5s and V8s (IRHV, 176 ± 92 mL; V5, 105 ± 49 mL; V8, 127 ± 60 mL; P < 0.001). The patency of IRHV was significantly improved by applying the double inferior vena cava method (93%, 94/101) when compared to the direct anastomosis to vena cava (68%, 25/37; P < 0.001). The IRHV functioned as a main drainage route in cases of an obstructed RHV. In conclusion, reconstruction of the IRHV is recommended, not only to improve the functional reserve of the graft, but also to secure multiple drainage routes of the graft.

22 October 2020 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
PDF file
MMMasaru Matsumura
Masaru Matsumura
YKYoshikuni Kawaguchi
Yoshikuni Kawaguchi
YKYuta Kobayashi
Yuta Kobayashi
KKKosuke Kobayashi
Kosuke Kobayashi
TITakeaki Ishizawa
Takeaki Ishizawa
KHKiyoshi Hasegawa
Kiyoshi Hasegawa